News

Jul 12, 2021
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance

PHILADELPHIA, July 12, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early-stage biotechnology company developing...

Read More
Jun 29, 2021
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors

PHILADELPHIA, June 29, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing...

Read More
Jun 23, 2021
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy

MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing...

Read More
Jun 2, 2021
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer

PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology...

Read More
May 20, 2021
HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs

Lausanne, Switzerland, 20 May 2021 -- HAYA Therapeutics, SA, a company developing precision medicines that...

Read More
Mar 23, 2021
Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.

PHILADELPHIA and NEW YORK, March 23, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor" or the "Company"), an...

Read More